275 related articles for article (PubMed ID: 36559105)
1. Photodynamic Opening of the Blood-Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors.
Semyachkina-Glushkovskaya O; Terskov A; Khorovodov A; Telnova V; Blokhina I; Saranceva E; Kurths J
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559105
[TBL] [Abstract][Full Text] [Related]
2. Music improves the therapeutic effects of bevacizumab in rats with glioblastoma: Modulation of drug distribution to the brain.
Semyachkina-Glushkovskaya O; Diduk S; Anna E; Elina D; Artem K; Khorovodov A; Shirokov A; Fedosov I; Dubrovsky A; Blokhina I; Terskov A; Navolokin N; Evsukova A; Elovenko D; Adushkina V; Kurths J
Front Oncol; 2022; 12():1010188. PubMed ID: 36313687
[TBL] [Abstract][Full Text] [Related]
3. EEG biomarkers of activation of the lymphatic drainage system of the brain during sleep and opening of the blood-brain barrier.
Semyachkina-Glushkovskaya OV; Karavaev AS; Prokhorov MD; Runnova AE; Borovkova EI; Yu M I; Hramkov AN; Kulminskiy DD; Semenova NI; Sergeev KS; Slepnev AV; Yu SE; Zhuravlev MO; Fedosov IV; Shirokov AA; Blokhina IA; Dubrovski AI; Terskov AV; Khorovodov AP; Ageev VB; Elovenko DA; Evsukova AS; Adushkina VV; Telnova VV; Postnov DE; Penzel TU; Kurths JG
Comput Struct Biotechnol J; 2023; 21():758-768. PubMed ID: 36698965
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic opening of the blood-brain barrier and pathways of brain clearing.
Semyachkina-Glushkovskaya O; Chehonin V; Borisova E; Fedosov I; Namykin A; Abdurashitov A; Shirokov A; Khlebtsov B; Lyubun Y; Navolokin N; Ulanova M; Shushunova N; Khorovodov A; Agranovich I; Bodrova A; Sagatova M; Shareef AE; Saranceva E; Iskra T; Dvoryatkina M; Zhinchenko E; Sindeeva O; Tuchin V; Kurths J
J Biophotonics; 2018 Aug; 11(8):e201700287. PubMed ID: 29380947
[TBL] [Abstract][Full Text] [Related]
5. Low-Level Laser Treatment Induces the Blood-Brain Barrier Opening and the Brain Drainage System Activation: Delivery of Liposomes into Mouse Glioblastoma.
Semyachkina-Glushkovskaya O; Bragin D; Bragina O; Socolovski S; Shirokov A; Fedosov I; Ageev V; Blokhina I; Dubrovsky A; Telnova V; Terskov A; Khorovodov A; Elovenko D; Evsukova A; Zhoy M; Agranovich I; Vodovozova E; Alekseeva A; Kurths J; Rafailov E
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839889
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine in Clinical Photodynamic Therapy for the Treatment of Brain Tumors.
Kim HS; Lee DY
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052776
[TBL] [Abstract][Full Text] [Related]
7. Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events.
Ibarra LE; Vilchez ML; Caverzán MD; Milla Sanabria LN
J Neurosci Res; 2021 Apr; 99(4):1024-1047. PubMed ID: 33370846
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine associated with photodynamic therapy for glioblastoma treatment.
de Paula LB; Primo FL; Tedesco AC
Biophys Rev; 2017 Oct; 9(5):761-773. PubMed ID: 28823025
[TBL] [Abstract][Full Text] [Related]
9. Application of optical coherence tomography for in vivo monitoring of the meningeal lymphatic vessels during opening of blood-brain barrier: mechanisms of brain clearing.
Semyachkina-Glushkovskaya O; Abdurashitov A; Dubrovsky A; Bragin D; Bragina O; Shushunova N; Maslyakova G; Navolokin N; Bucharskaya A; Tuchin V; Kurths J; Shirokov A
J Biomed Opt; 2017 Dec; 22(12):1-9. PubMed ID: 29275545
[TBL] [Abstract][Full Text] [Related]
10. Advances in Nanotechnology-Based Immunotherapy for Glioblastoma.
Tang L; Zhang M; Liu C
Front Immunol; 2022; 13():882257. PubMed ID: 35651605
[TBL] [Abstract][Full Text] [Related]
11. The Role of Photodynamic Therapy in Triggering Cell Death and Facilitating Antitumor Immunology.
Tan L; Shen X; He Z; Lu Y
Front Oncol; 2022; 12():863107. PubMed ID: 35692783
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine-Based Strategies Assisting Photodynamic Therapy for Hypoxic Tumors: State-of-the-Art Approaches and Emerging Trends.
Shih CY; Wang PT; Su WC; Teng H; Huang WL
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33535466
[TBL] [Abstract][Full Text] [Related]
13. Insight into the Prospects for Tumor Therapy Based on Photodynamic Immunotherapy.
Cheng X; Wei Y; Jiang X; Wang C; Liu M; Yan J; Zhang L; Zhou Y
Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36355531
[TBL] [Abstract][Full Text] [Related]
14. Age differences in photodynamic therapy-mediated opening of the blood-brain barrier through the optical clearing skull window in mice.
Zhang C; Feng W; Li Y; Kürths J; Yu T; Semyachkina-Glushkovskaya O; Zhu D
Lasers Surg Med; 2019 Sep; 51(7):625-633. PubMed ID: 30811633
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in AIEgen-Based Photodynamic Therapy and Immunotherapy.
Zha M; Yang G; Li Y; Zhang C; Li B; Li K
Adv Healthc Mater; 2021 Dec; 10(24):e2101066. PubMed ID: 34519181
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy.
Ji B; Wei M; Yang B
Theranostics; 2022; 12(1):434-458. PubMed ID: 34987658
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic Therapy for the Treatment of Glioblastoma.
Cramer SW; Chen CC
Front Surg; 2019; 6():81. PubMed ID: 32039232
[TBL] [Abstract][Full Text] [Related]
18. In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma.
Jeising S; Geerling G; Guthoff R; Hänggi D; Sabel M; Rapp M; Nickel AC
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103049. PubMed ID: 35932958
[TBL] [Abstract][Full Text] [Related]
19. Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.
Albert I; Hefti M; Luginbuehl V
Neurol Res; 2014 Nov; 36(11):1001-10. PubMed ID: 24923209
[TBL] [Abstract][Full Text] [Related]
20. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
